Optiva Inc.

TSX (CAD): Optiva Inc. (OPT)

Last Price

3.42

Today's Change

0.00 (0.00%)

Day's Change

0.00 - 0.00

Trading Volume

0

Overview

Market Cap

21 Million

Shares Outstanding

6 Million

Avg Volume

1,468

Avg Price (50 Days)

3.67

Avg Price (200 Days)

5.49

PE Ratio

-0.80

EPS

-4.28

Earnings Announcement

04-Mar-2025

Previous Close

3.42

Open

3.45

Day's Range

3.42 - 3.45

Year Range

1.98 - 9.28

Trading Volume

1,902

Price Change Highlight

1 Day Change

0.00%

5 Day Change

0.00%

1 Month Change

14.00%

3 Month Change

-25.65%

6 Month Change

-54.34%

Ytd Change

13.62%

1 Year Change

-20.47%

3 Year Change

-82.90%

5 Year Change

-93.36%

10 Year Change

-98.28%

Max Change

-94.61%

News and Blogs

No result.

Company Profile

Sector: Technology - Technology

Industry: Software—Infrastructure

Description:

Optiva Inc. provides cloud-native monetization and revenue management software to communication service providers (CSP) in Europe, the Middle East, Africa, North America, Latin America, the Caribbean, Asia, and the Pacific Rim. The company's monetization products enable real-time charging, rating, billing, product catalog, policy management, and customer care for any digital services of a CSP. Its solutions include Optiva Charging Engine, a convergent charging solution that helps CSPs to monetize platform; Optiva Business Support System Platform, an end-to-end cloud native converged charging and billing solutions on the private and public cloud; Policy Control, a data monetization for real-time applications, such as video streaming, interactive gaming, and voice over LTE; and Optiva Wholesale Billing, a cloud-based solution that provides converged settlement and accurate interconnect billing. The company also offers Optiva Payment solutions that include various payment methods, including voucher and voucher less payment and top-up solutions. The company was founded in 1999 and is headquartered in Mississauga, Canada.

Discussions
Be the first to like this. Showing 0 of 0 comments

Post a Comment